Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Equity Placing

9 Sep 2008 14:19

RNS Number : 0555D
Ovoca Gold PLC
09 September 2008
Β 

ο»Ώ

Ovoca Gold PLCΒ ("Ovoca" or the "Company")

EquityΒ Placing

OvocaΒ (London AIM (OVG.L), Frankfurt (OVX.GR) and Dublin IEX (OVX.IR)Β is pleased to announce that it has agreed the terms of a conditional placing ofΒ 6,471,000Β new ordinary shares of €0.025 each ("Ordinary Share") at a price ofΒ Β£0.065Β per Ordinary Share (the 'Placing Shares'), raising gross proceeds of Β£420,615Β ("the Placing").Β 

The Placing priceΒ isΒ aΒ 10.9%Β premiumΒ to the average mid marketΒ closingΒ price on the London Stock Exchange ofΒ Β£0.059Β per Ordinary share on the ten trading daysΒ prior toΒ 9Β SeptemberΒ 2008.Β Β In addition,Β the CompanyΒ has issued warrants to subscribeΒ forΒ 3,235,500Β Ordinary SharesΒ which have an exercise price ofΒ Β£0.082Β per shareΒ andΒ can be exercisedΒ at any time up toΒ 4Β SeptemberΒ 2009.Β Β The warrants, which are transferable, will not be quoted on any market.Β The Placing is conditional on the Placing Shares being admitted to trading onΒ the IEX Market of theΒ Irish Stock Exchange ("IEX") andΒ the AIM Market of the London StockΒ ExchangeΒ ("AIM").

The net proceeds of the PlacingΒ willΒ be usedΒ inΒ the evaluation and development of theΒ GoltsovoyeΒ silver deposit, located in the Magadan Oblast of north-eastΒ Russia,Β and for working capital purposes.Β 

Leonid Skoptsov, CEOΒ of Ovoca,Β will subscribe for the following Placing Shares:

Β 
Β 
Placing Shares subscribed for:
Resultant holding of Ordinary Shares:
% of Enlarged Share Capital:
Subishico Trading Company Ltd*
2,157,000
39,578,743
8.9536
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Warrants received pursuant to the Placing:
Resultant holding of Warrants:
Subishico Trading Company Ltd*
Β 
1,078,500
4,943,225
Β 
Β 
Β 
Β 
Β 

*Β The Saint George Trust, of which Leonid Pavlovich Skoptsov is a director and beneficial owner of, isΒ aΒ beneficial shareholder in Subishico Trading Co Ltd.

ApplicationΒ willΒ be made to the Irish Stock Exchange and the London Stock Exchange for the placing shares to be admitted to trading on IEX and AIM respectively Admission is expected to occur byΒ 16Β SeptemberΒ 2008.

For further information please visitΒ www.ovocagold.com,Β www.ovocagold.euΒ Β or contact:

Leonid Skoptsov - Ovoca Gold Plc

Tel + 7 (0)495 648 2646

Email:Β leonid.skoptsov@ovocagold.com

Danesh Varma - Ovoca Gold Plc

Tel: 08452 606 034 Fax: 020 7653 9889Β Email:Β danesh.varma@ovocagold.com

John Frain - Davy

TelΒ : +353 (0)1 679 6363Β 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange.


This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEUUUBUBUPRGWB
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.